Key Parameters For Success In Treating Dementia - Dale Bredesen, MD

new 22-Key Parameters For Success In Treating Dementia - Dale Bredesen, MD

Dale Bredesen, MD
• https://www.ahnphealth.com/dr-bredesen.html
• Book - End of Alzheimer’s: The First Program to Prevent and Reverse Cognitive Decline

#DaleBredesen #Alzheimer's #Dementia #CognitiveDecline

0:48 Understanding Cognitive Decline in Alzheimer's Disease
11:45 A Pandemic That Actually Dwarfs the Covid 19 Pandemic
21:20 Reduction in Alzheimer's Disease If People Would Get On Active Prevention
35:08 The Most Common Genetic Risk Factor for Alzheimer's
47:12 Alzheimer's Disease Should Be Optional Instead of Unavoidable
113:11 The Gene That Puts You at Risk For Chronic Ongoing Inflammation
119:29 Are There Toxins Actually Bound To Your DNA That Are Impacting You?
125:37 The Average Person Who Develops Alzheimer's Spends By Death $350,000
133:57 Do Estrogen Blockers Affect My Brain?
139:33 The Biggest Heavy Metal We Worry About With Cognitive Decline

Dr. Dale Bredesen’s is an author and internationally-recognized expert in the mechanisms of neurodegenerative diseases, and is a New York Times bestselling author for - The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline

This book is a groundbreaking plan to prevent and reverse Alzheimer’s Disease that fundamentally changes how we understand cognitive decline.

Everyone knows someone who has survived cancer, but until now no one knows anyone who has survived Alzheimer's Disease.

In this paradigm shifting book, Dale Bredesen, MD, offers real hope to anyone looking to prevent and even reverse Alzheimer's Disease and cognitive decline. Revealing that AD is not one condition, as it is currently treated, but three, The End of Alzheimer’s outlines 36 metabolic factors (micronutrients, hormone levels, sleep) that can trigger "downsizing" in the brain. The protocol shows us how to rebalance these factors using lifestyle modifications like taking B12, eliminating gluten, or improving oral hygiene.

The results are impressive. Of the first ten patients on the protocol, nine displayed significant improvement with 3-6 months; since then the protocol has yielded similar results with hundreds more. Now, The End of Alzheimer’s brings new hope to a broad audience of patients, caregivers, physicians, and treatment centers with a fascinating look inside the science and a complete step-by-step plan that fundamentally changes how we treat and even think about AD.

Dr. Dale Bredesen’s career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible. Thanks to a dedicated pursuit of finding the science that makes this a reality, his idea has placed Dr. Bredesen at the vanguard of neurological research, and led to the discoveries that today underlie the ReCode Report.
Dr. Bredesen earned his MD from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO.
Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable
early results.
Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his finding and research into the 2017 New York Times best-seller The End of Alzheimer’s.
To Contact Dr Bredesen go to ApolloHealthCo.com